Yamamoto M - Search Results

1

Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases.

Kuramochi H, Nakajima G, Kaneko Y, Nakamura A, Inoue Y, Yamamoto M, Hayashi K. Kuramochi H, et al. Among authors: yamamoto m. BMC Cancer. 2012 Mar 13;12:88. doi: 10.1186/1471-2407-12-88. BMC Cancer. 2012. PMID: 22409860 Free PMC article.

2

Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma.

Matsumura N, Yamamoto M, Aruga A, Takasaki K, Nakano M. Matsumura N, et al. Among authors: yamamoto m. Cancer. 2002 Mar 15;94(6):1770-6. doi: 10.1002/cncr.10398. Cancer. 2002. PMID: 11920540 Free article.

3

Combination therapy of S-1 and CDDP for patients with colorectal cancer.

Uchida K, Hayashi K, Kuramochi H, Nakajima G, Inoue Y, Yamamoto M. Uchida K, et al. Among authors: yamamoto m. J Cancer Res Clin Oncol. 2007 Nov;133(11):841-6. doi: 10.1007/s00432-007-0226-9. Epub 2007 May 4. J Cancer Res Clin Oncol. 2007. PMID: 17479286

4

Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer.

Nakajima G, Hayashi K, Xi Y, Kudo K, Uchida K, Takasaki K, Yamamoto M, Ju J. Nakajima G, et al. Among authors: yamamoto m. Cancer Genomics Proteomics. 2006 Oct;3(5):317-324. Cancer Genomics Proteomics. 2006. PMID: 18172508 Free PMC article.

5

High intratumoral dihydropyrimidine dehydrogenase mRNA levels in pancreatic cancer associated with a high rate of response to S-1.

Kuramochi H, Hayashi K, Uchida K, Nakajima G, Hatori T, Danenberg KD, Danenberg PV, Yamamoto M. Kuramochi H, et al. Among authors: yamamoto m. Cancer Chemother Pharmacol. 2008 Dec;63(1):85-9. doi: 10.1007/s00280-008-0714-x. Epub 2008 Feb 29. Cancer Chemother Pharmacol. 2008. PMID: 18309485 Clinical Trial.

6

ERCC1 codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy.

Kamikozuru H, Kuramochi H, Hayashi K, Nakajima G, Yamamoto M. Kamikozuru H, et al. Among authors: yamamoto m. Int J Oncol. 2008 May;32(5):1091-6. Int J Oncol. 2008. PMID: 18425336 Clinical Trial.

7

[Three cases of stomatitis caused by chemotherapy for gastrointestinal cancer that responded well to lafutidine].

Uchida K, Hayashi K, Kuramochi H, Nakajima G, Yamamoto M. Uchida K, et al. Among authors: yamamoto m. Gan To Kagaku Ryoho. 2008 Aug;35(8):1435-8. Gan To Kagaku Ryoho. 2008. PMID: 18701867 Japanese.

8

[The analysis of CCR4+/CXCR3+ cell ratio in gastrointestinal cancer patients receiving chemotherapy or immunotherapy].

Sakuyama R, Aruga A, Kuramochi H, Matsushita N, Kotera Y, Takeshita S, Hayashi K, Yamamoto M. Sakuyama R, et al. Among authors: yamamoto m. Gan To Kagaku Ryoho. 2008 Nov;35(12):2259-61. Gan To Kagaku Ryoho. 2008. PMID: 19106589 Japanese.

9

[An appropriate chemotherapy for esophageal cancer from a histological standpoint].

Hayashi K, Nakamura T, Narumiya K, Yamamoto M. Hayashi K, et al. Among authors: yamamoto m. Gan To Kagaku Ryoho. 2009 Feb;36(2):182-6. Gan To Kagaku Ryoho. 2009. PMID: 19223733 Japanese.

10

Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases.

Kuramochi H, Hayashi K, Nakajima G, Kamikozuru H, Yamamoto M, Danenberg KD, Danenberg PV. Kuramochi H, et al. Among authors: yamamoto m. Cancer Chemother Pharmacol. 2010 Apr;65(5):825-31. doi: 10.1007/s00280-009-1087-5. Epub 2009 Aug 22. Cancer Chemother Pharmacol. 2010. PMID: 19701635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,366 results

Search Page

Filters